AOF
LIVE

Serial Number

87619921

Owner

Pfanstiehl, Inc.

Attorney

Paul C. Llewellyn

First Use Date

Jul 20, 2020

Filing Date

Sep 23, 2017

Add to watchlist:

No watchlists yet
View on USPTO

AOF Trademark

Serial Number: 87619921 • Registration: 6211471

AOF is a trademark filed by Pfanstiehl, Inc. on September 23, 2017. The trademark is classified under Class 1 (Chemicals), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Pfanstiehl, Inc. (32 trademarks)

Waukegan, IL 60085

Entity Type: 03

Trademark Details

Filing Date

September 23, 2017

Registration Date

December 1, 2020

First Use Anywhere

July 20, 2020

First Use in Commerce

July 20, 2020

Published for Opposition

February 6, 2018

Goods & Services

Chemicals and biochemicals for use in the formulation, development and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, finished drug products, parenteral drugs and therapies; Chemicals and biochemicals for use in biotechnological product development and manufacturing processes; excipients and active ingredients for use in development, formulation and manufacture of pharmaceuticals, biopharmaceuticals, vaccines, injectable formulations, pharmaceutical intermediaries and drug formulations; chemicals, biochemicals, stabilizers, catalysts, enzymes, formulation ingredients, additives, drug delivery molecules and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; active pharmaceutical ingredients for use in the manufacture of pharmaceuticals, biopharmaceuticals, vaccines, and finished drug products; formulation ingredients, additives, drug delivery molecules, and carriers, and buffers, all for use in the pharmaceutical and biopharmaceutical industry; pharmaceutical intermediates for use in the pharmaceutical and biopharmaceutical industry; biochemical excipients for use in the pharmaceutical and biopharmaceutical industry; biochemical catalysts; biochemical preservers and protectors for use in the pharmaceutical and biopharmaceutical industry

Biochemical research and development; Chemical, biochemical, biological and bacteriological research and analysis; Drug discovery services; Pharmaceutical drug development services; Product research and development; Research and development in the pharmaceutical and biotechnology fields; Research and development of vaccines and medicines

Filing History

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Dec 1, 2025 REM1
REGISTERED-PRINCIPAL REGISTER
Dec 1, 2020 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Oct 27, 2020 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Oct 24, 2020 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Oct 5, 2020 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Oct 5, 2020 AITU
USE AMENDMENT FILED
Sep 21, 2020 IUAF
TEAS STATEMENT OF USE RECEIVED
Sep 21, 2020 EISU
SOU TEAS EXTENSION RECEIVED
Sep 17, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 4, 2020 EXRA
SOU EXTENSION 4 GRANTED
Apr 2, 2020 EX4G
SOU EXTENSION 4 FILED
Apr 2, 2020 EXT4
SOU TEAS EXTENSION RECEIVED
Apr 2, 2020 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 4, 2019 EXRA
SOU EXTENSION 3 GRANTED
Oct 2, 2019 EX3G
SOU EXTENSION 3 FILED
Oct 2, 2019 EXT3
SOU TEAS EXTENSION RECEIVED
Oct 2, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Mar 30, 2019 EXRA
SOU EXTENSION 2 GRANTED
Mar 28, 2019 EX2G
SOU EXTENSION 2 FILED
Mar 28, 2019 EXT2
SOU TEAS EXTENSION RECEIVED
Mar 28, 2019 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 12, 2018 EXRA
SOU EXTENSION 1 GRANTED
Sep 10, 2018 EX1G
SOU EXTENSION 1 FILED
Sep 10, 2018 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 10, 2018 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Apr 3, 2018 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Feb 6, 2018 NPUB
PUBLISHED FOR OPPOSITION
Feb 6, 2018 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 17, 2018 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Dec 30, 2017 CNSA
ASSIGNED TO EXAMINER
Dec 29, 2017 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 28, 2017 NWOS
NEW APPLICATION ENTERED
Sep 27, 2017 NWAP